Longevity Health (NASDAQ:XAGE) Shares Up 0.4% – Should You Buy?

Longevity Health Holdings, Inc. (NASDAQ:XAGE) shares were up 0.4% during trading on Wednesday . The stock traded as high as $0.3121 and last traded at $0.3121. Approximately 524 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 2,837 shares. The stock had previously closed at $0.3110.

Longevity Health Stock Performance

The firm has a market capitalization of $556,162.20, a P/E ratio of -0.06 and a beta of 0.28. The firm’s 50-day moving average is $0.33 and its 200 day moving average is $0.38.

About Longevity Health

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.